Español
The mission of the OLIGOFATSX project is to develop oligonucleotide-based medicines to improve the quality of life of patients affected by rare diseases for which there is still no solution. The scientists involved in the project firmly believe that the future of personalised precision medicine lies in the successful combination of different technologies, including oligonucleotides; […]
Author Archives: oligofastx
International Biotechnology Day 2024, Technology
Enzymes: key molecules for the development of oligonucleotides
21
Jun
Jun
The OLIGOFASTX team is focused on the development of oligonucleotide-based therapies for certain rare diseases covering the whole cycle: from research to manufacturing and distribution of future new oligonucleotide-based drugs. To this end, the companies that make up the consortium are specialised in one area, which in combination provides a form of collaboration that allows […]
15
Jun
Jun
Clear and accessible science communication is essential to bring research advances closer to the general public and to foster understanding and interest in science. In this blog, we will explore the importance of effective communication in science and how it can improve the dissemination of research results. According to a study by Nature, only a […]
09
Jun
Jun
Nanotechnology is a field that has revolutionised the pharmaceutical industry. The ability to manipulate materials on a scale as tiny as nanometres allows scientists to create drug delivery systems that make them more effective in treating disease and safer for the patient. In fact, it is a strategic technology for OLIGOFASTX, a consortium which, although […]
Rare Diseases, Rare diseases
Hope for patients with Fuchs’ Endothelial Corneal Dystrophy: Innovations in treatment
31
May
May
Today we talk in our blog about another of the rare diseases that the OLIGOFASTX consortium is working on: Fuchs’ Corneal Endothelial Endothelial Dystrophy (FECD). This pathology affects approximately 4% of the population over 40 years of age, and much more women than men. Results from miRNA expression profiling in FECD endothelial cells demonstrates widespread […]
24
May
May
The European Week Against Cancer takes place from 25 to 31 May to raise awareness of cancer prevention, access to treatment and support for cancer survivors. From OLIGOFASTX we wanted to offer an overview of the current situation regarding the fight against this disease on the occasion of this week. In recent years, there have […]
18
May
May
May 20 marks International Clinical Trials Day, a date designed to highlight the importance of clinical research and the participation of patients and volunteers that contributes to saving lives, to economic and social development and to providing benefits to healthcare systems. From OLIGOFASTX we do not want to miss the opportunity to address the subject […]
11
May
May
Technological evolution is increasingly present in all areas of our lives. In today’s article we look at how its application in the chemical sciences through what is known as Computational Chemistry influences the development of modern chemistry, biochemistry, physics and materials science. This role has been widely recognized by the international scientific community and this […]
History of biotechnology, International Biotechnology Day 2024, Noticias
The experiment that helped crack the code of life
28
Apr
Apr
In 1961, Marshall Nirenberg and Heinrich Matthaei discovered the genetic code of living beings, which confirms that the information contained in DNA is expressed in proteins according to a defined pattern. These researchers at the U.S. National Institutes of Health (NIH) made one of the scientific milestones that changed our view of how life develops […]
18
Apr
Apr
Today, the OLIGOFASTX team joins in the celebration of the European Patients’ Rights Day, a relatively recent initiative promoted by the Active Citizenship Network. In 2002, the European organization promulgated the Charter of Patients’ Rights, which sets out the fourteen rights that patients throughout Europe should have in all healthcare facilities. Known as Patients’ Rights […]